Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis

por Hoogwerf, Byron J., Lincoff, A. Michael, Rodriguez, Angel, Chen, Lei, Qu, Yongming
Publicado 2016

Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart

por Attia, Tamer, Robich, Michael, Lincoff, A. Michael, Shishehbor, Mehdi H., Svensson, Lars, Smedira, Nicholas G.
Publicado 2017

THU584 Comparison Of The Cardiovascular Benefits Of Bempedoic Acid With Statins- Analysis By The Cholesterol Treatment Trialists’ Methodology

por Lincoff, A Michael, Ray, Kausik, Sasiela, William, Haddad, Tariq, Nicholls, Stephen, Li, Na, Cho, Leslie, Mason, Denise, Libby, Peter, Nissen, Steven
Publicado 2023

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phas...

por Ruilope, Luis, Hanefeld, Markolf, Lincoff, A Michael, Viberti, Giancarlo, Meyer-Reigner, Sylvie, Mudie, Nadejda, Wieczorek Kirk, Dominika, Malmberg, Klas, Herz, Matthias
Publicado 2014

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery

por Reed, Grant W., Horr, Samuel, Young, Laura, Clevenger, Joshua, Malik, Umair, Ellis, Stephen G., Lincoff, A. Michael, Nissen, Steven E., Menon, Venu
Publicado 2017

Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis

por Khan, Safi U., Rahman, Hammad, Okunrintemi, Victor, Riaz, Haris, Khan, Muhammad Shahzeb, Sattur, Sudhakar, Kaluski, Edo, Lincoff, A. Michael, Martin, Seth S., Blaha, Michael J.
Publicado 2019

Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction

por Nair, Raunak, Johnson, Michael, Kravitz, Kathleen, Huded, Chetan, Rajeswaran, Jeevanantham, Anabila, Moses, Blackstone, Eugene, Menon, Venu, Lincoff, A. Michael, Kapadia, Samir, Khot, Umesh N.
Publicado 2021

Impact of a Comprehensive ST‐Segment–Elevation Myocardial Infarction Protocol on Key Process Metrics in Black Americans

por Nair, Raunak M., Kumar, Anirudh, Huded, Chetan P., Kravitz, Kathleen, Reed, Grant W., Krishnaswamy, Amar, Menon, Venu, Lincoff, A. Michael, Kapadia, Samir R., Khot, Umesh N.
Publicado 2023

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial

por Pencina, Karol M., Travison, Thomas G., Artz, Andrew S., Lincoff, A. Michael, Nissen, Steven E., Flevaris, Panagiotis, Chan, Anna, Li, Xue, Diegel, Scott A., Wannemuehler, Kathleen, Bhasin, Shalender
Publicado 2023

Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention

por Marquis‐Gravel, Guillaume, Boivin‐Proulx, Laurie‐Anne, Huang, Zhen, Zelenkofske, Steven L., Lincoff, A. Michael, Mehran, Roxana, Steg, P. Gabriel, Bode, Christoph, Alexander, John H., Povsic, Thomas J.
Publicado 2022

Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial

por Koomen, Jeroen V., Heerspink, Hiddo J. L., Schrieks, Ilse C., Schwartz, Gregory G., Lincoff, A. Michael, Nicholls, Stephen J., Svensson, Anders, Wedel, Hans, Weichert, Arlette, Grobbee, Diederick E., Stevens, Jasper
Publicado 2019

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial

por Kumar, Anirudh, Patel, Divyang R., Brennan, Danielle M., Wolski, Kathy E., Lincoff, A. Michael, Ruotolo, Giacomo, McErlean, Ellen, Weerakkody, Govinda, Riesmeyer, Jeffrey S., Nicholls, Stephen J., Nissen, Steven E., Menon, Venu
Publicado 2019

Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascu...

por Grobbee, Esmée J., de Jong, Vivian D., Schrieks, Ilse C., Tushuizen, Maarten E., Holleboom, Adriaan G., Tardif, Jean-Claude, Lincoff, A. Michael, Schwartz, Gregory G., Castro Cabezas, Manuel, Grobbee, Diederick E.
Publicado 2022

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

por Menon, Venu, Kumar, Anirudh, Patel, Divyang R., John, Julie St., Wolski, Kathy E., McErlean, Ellen, Riesmeyer, Jeffrey S., Weerakkody, Govinda, Ruotolo, Giacomo, Cremer, Paul C., Nicholls, Stephen J., Lincoff, A. Michael, Nissen, Steven E.
Publicado 2019

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial

por Menon, Venu, Kumar, Anirudh, Patel, Divyang R, St John, Julie, Riesmeyer, Jeffrey, Weerakkody, Govinda, Ruotolo, Giacomo, Wolski, Kathy E, McErlean, Ellen, Cremer, Paul C, Nicholls, Stephen J, Lincoff, A Michael, Nissen, Steven E
Publicado 2020

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac inj...

por Sheng, Calvin C, Sahoo, Debasis, Dugar, Siddharth, Prada, Robier Aguillon, Wang, Tom Kai Ming, Abou Hassan, Ossama K, Brennan, Danielle, Culver, Daniel A, Rajendram, Prabalini, Duggal, Abhijit, Lincoff, A Michael, Nissen, Steven E, Menon, Venu, Cremer, Paul C
Publicado 2020

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time

por Huded, Chetan P., Kapadia, Samir R., Ballout, Jad A., Krishnaswamy, Amar, Ellis, Stephen G., Raymond, Russell, Cho, Leslie, Simpfendorfer, Conrad, Bajzer, Chris, Martin, Joseph, Nair, Ravi, Lincoff, A. Michael, Kravitz, Kathleen, Menon, Venu, Hantz, Scott, Khot, Umesh N.
Publicado 2020

Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI

por Kumar, Anirudh, Zhou, Leon, Huded, Chetan P., Moennich, Laurie Ann, Menon, Venu, Puri, Rishi, Reed, Grant W., Nair, Ravi, Khatri, Jaikirshan J., Krishnaswamy, Amar, Lincoff, A. Michael, Ellis, Stephen G., Ziada, Khaled M., Kapadia, Samir R., Khot, Umesh N.
Publicado 2021

Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary Intervention

por Kumar, Anirudh, Ogunnowo, Gregory O., Khot, Umesh N., Raphael, Claire E., Ghobrial, Joanna, Rampersad, Penelope, Puri, Rishi, Khatri, Jaikirshan J., Reed, Grant W., Krishnaswamy, Amar, Cho, Leslie, Lincoff, A. Michael, Ziada, Khaled M., Kapadia, Samir R., Ellis, Stephen G.
Publicado 2022

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

por Lingvay, Ildiko, Brown‐Frandsen, Kirstine, Colhoun, Helen M., Deanfield, John, Emerson, Scott S., Esbjerg, Sille, Hardt‐Lindberg, Søren, Hovingh, G. Kees, Kahn, Steven E., Kushner, Robert F., Lincoff, A. Michael, Marso, Steven P., Fries, Tea Monk, Plutzky, Jorge, Ryan, Donna H.
Publicado 2022